Aurinia Pharmaceuticals Gets European Commission Approval Of Lupkynis For The The Treatment Of Adults With Active Lupus Nephritis
https://ec.europa.eu/transparency/documents-register/detail?ref=C(2022)6734&lang=en
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
Gainers
Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.
Why Aurinia Pharmaceuticals Stock Is Plunging
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading lower Tuesday after the company received a notice regarding the U.S. Patent Office Patent Trial and Appeal Board's decision to institute trial.
Aurinia Pharmaceuticals Receives Notice Regarding USPTO Trial And Appeal Board Decision To Institute Trial On Inter Partes Review Filed By Sun Pharmaceuticals
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) ("Aurinia" or the "Company") today received notice regarding the U.S. Patent Office (USPTO) Patent Trial and Appeal Board (PTAB) decision to institute trial
Why Bank Stocks Traded Sharply Higher; Here’s 65 Biggest Movers From Friday
Gainers
United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.